{
    "Trade/Device Name(s)": [
        "Pocguide Multi-Drug Test Panel",
        "Pocguide Multi-Drug Test Panel OTC",
        "PocguideTM Multi-Drug Test Panel",
        "PocguideTM Multi-Drug Test Panel OTC"
    ],
    "Submitter Information": "Aicheck Biotech, Inc.",
    "510(k) Number": "K242498",
    "Predicate Device Reference 510(k) Number(s)": [
        "K202567"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NGL",
        "PTH",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "NGM",
        "QAW",
        "NFW"
    ],
    "Summary Letter Date": "August 22, 2024",
    "Summary Letter Received Date": "August 22, 2024",
    "Submission Date": "August 15, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3650",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Opiate test system",
        "Barbiturate test system",
        "Benzodiazepine test system",
        "Cocaine and Cocaine Metabolites Test System",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Oxazepam",
        "Benzoylecognine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine",
        "Methamphetamine",
        "Methylenedioxy-methamphetamine",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Nortriptyline",
        "Marijuana"
    ],
    "Specimen Type(s)": [
        "Urine",
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay",
        "Antigen-antibody reaction"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Strip test",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for Pocguide Multi-Drug Test Panel and OTC, a lateral flow immunochromatographic device for qualitative detection of multiple drugs of abuse in urine.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of amphetamine, buprenorphine, secobarbital, oxazepam, cocaine, EDDP, methamphetamine, MDMA, morphine, methadone, oxycodone, phencyclidine, nortriptyline and marijuana in human urine for in vitro diagnostic and over-the-counter use.",
    "fda_folder": "Toxicology"
}